RT Journal Article
T1 In Vitro Activity of Tedizolid against Mycobacterium tuberculosis.
A1 Ruiz, Pilar
A1 Causse, Manuel
A1 Vaquero, Manuel
A1 Casal, Manuel
K1 Mycobacterium tuberculosis
K1 resistance
K1 tedizolid
AB Tedizolid is a novel oxazolidinone with activities against Gram-positive microorganisms, including mycobacteria. We studied the in vitro activity of tedizolid against 120 Mycobacterium tuberculosis strains, including susceptible, first-line-resistant, and multidrug-resistant isolates. MIC was tested using the Bactec 960 MGIT system. MIC90 and MIC50 were 0.5 and 0.25 μg/ml, respectively, in susceptible and resistant strains. Tedizolid may be an alternative in the treatment of resistant M. tuberculosis.
YR 2019
FD 2019-03-27
LK https://hdl.handle.net/10668/25536
UL https://hdl.handle.net/10668/25536
LA en
DS RISalud
RD Apr 17, 2025